|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 31/137 | (2006.01) |
| (11) | Patento numeris | 2465492 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12155251.7 |
| Europos patento paraiškos padavimo data | 2008-10-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 979482 P | 2007-10-12 | US |
| (72) |
Ruegger, Colleen, US
Ambühl, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Compositions comprising sphingosine I phosphate (sip) receptor modulators |
| Compositions comprising sphingosine I phosphate (sip) receptor modulators |